Search results

During a visit to Angola held 21-28 January, World Council of Churches (WCC) staff met with local church and community leaders to discuss how preventing obstetric fistula is a matter of human rights.

During a webinar presented by the Conference of Non-Governmental Organizations in Consultative Relationship with the United Nations (CoNGO) and hosted by the World Council of Churches (WCC), civil society and faith-based groups explored their shared commitment to the Universal Declaration of Human Rights. 

Two World Council of Churches (WCC) HIV initiatives met to review and celebrate the critical and life-changing work of the initiatives and to continue planning for a strengthened WCC HIV response in the new WCC Commission of the Churches on Health and Healing.

World Council of Churches (WCC) specialized ministries and roundtable partners are gathering on 3-4 May at the Bossey Ecumenical Institute for a “Working Together” meeting filled with a spirit of interconnected learning and preparation for the WCC 11th Assembly.

As a United Nations high-level meeting convenes from 8-10 June in New York, the World Council of Churches (WCC) is joining the UN and other faith-based and civic groups to review progress on commitments to end the AIDS epidemic by 2030.

The World Council of Churches (WCC) executive committee, convening from 17-20 May, set a tone of hope for the future while, at the same time, addressing multiple global crises with statements, pastoral messages, and calls for prayer.

Under the title “Christ’s Love in the Midst of Pandemic: Moving the World to Reconciliation and Solidarity,” the World Council of Churches (WCC) journal The Ecumenical Review explores a range of theological, spiritual, and societal questions raised by the COVID-19 pandemic.

 

A 13 Million Campaign is underway to engage faith leaders, individuals and communities in promoting access to health services for the 13 million children, women and men living with HIV who are not yet on antiretroviral treatment.

For World AIDS Day 2019, the World Council of Churches (WCC) embraces the theme "Communities make the difference." World AIDS Day is being commemorated in the context of 16 Days Against Gender-based Violence, an annual international campaign that began on 25 November and ends on 10 December, Human Rights Day. The WCC also helps bring about grassroots awareness and change through the Thursdays in Black campaign for a world free from rape and violence.

The latest issue of The Ecumenical Review, the quarterly journal of the World Council of Churches, opens with an article by WCC general secretary the Rev. Dr Olav Fykse Tveit, “Freedom, Love and Justice,” reflecting on the theme for the WCC's 11th Assembly in 2021, “Christ's love moves the world to reconciliation and unity.”

A publication entitled “When Food Becomes Immaterial: Confronting the Digital Age” is now available to help people explore the impact of technologies on what and how we eat, as well as on how food is produced.

The WCC is mourning the death of Calle Almedal, a great friend of WCC and of all faith communities, as well as a pioneer in the field of HIV. Almedal passed away on 7 June.

The WCC-EAA is inviting a “letter writing action”, encouraging religious leaders and faith communities to speak out for action against Tuberculosis (TB).

At a consultation in Seoul on December 7-11, participants from churches throughout northeast Asia shared insights on diakonia and how vital it is to the nature and mission of the church.

“What do we have the right to manipulate in creation?” The question is at the heart of a Canadian Quaker’s commitment to the process of encouraging member churches of the World Council of Churches (WCC) to reflect on scientific experiments in modifying life forms known as “synthetic biology”.

The World Council of Churches - Ecumenical Advocacy Alliance endorses a newly expanded collaboration on HIV between the Medicine Patent Pool and Gilead. On 4 October, the MPP announced a licence with Gilead Sciences for bictegravir, a new integrase inhibitor part of a once-daily, single-tablet HIV regimen currently filed for regulatory approval at the United States Food and Drug Administration and the European Union.